Molecular Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention Bridging the Lab and the Clinic in Cancer Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

Molecular Cancer Research 5, 473-484, May 1, 2007. doi: 10.1158/1541-7786.MCR-06-0395
© 2007 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kim, M.-S.
Right arrow Articles by Kim, S. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kim, M.-S.
Right arrow Articles by Kim, S. G.


Signaling and Regulation

G{alpha}12/13 Basally Regulates p53 through Mdm4 Expression

Mi-Sung Kim1, Sang Min Lee1, Won Dong Kim1, Sung Hwan Ki1, Aree Moon2, Chang Ho Lee3 and Sang Geon Kim1

1 College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University; 2 College of Pharmacy, Duksung Women's University; and 3 Department of Pharmacology and Institute of Biomedical Science, College of Medicine, Hanyang University, Seoul, Korea

Requests for reprints: Sang Geon Kim, College of Pharmacy, Seoul National University, Sillim-dong, Kwanak-Gu, Seoul 151-742, Korea. Phone: 82-2880-7840; Fax: 82-2872-1795. E-mail: sgk{at}snu.ac.kr

G{alpha}12/13, which belongs to the G{alpha}12 family, participates in the regulation of diverse physiologic processes. In view of the control of G{alpha}12/13 in cell proliferation, this study investigated the role of G{alpha}12/13 in the regulation of p53 and mdm4. Immunoblotting and immunocytochemistry revealed that p53 was expressed in control embryonic fibroblasts and was largely localized in the nuclei. G{alpha}12 deficiency decreased p53 levels and its DNA binding activity, accompanying p21 repression with Bcl2 induction, whereas G{alpha}13 deficiency exerted weak effects. G{alpha}12 or G{alpha}13 deficiency did not change p53 mRNA expression. ERK1/2 or Akt was not responsible for p53 repression due to G{alpha}12 deficiency. Mdm4, a p53-stabilizing protein, was repressed by G{alpha}12 deficiency and to a lesser extent by G{alpha}13 deficiency, whereas mdm2, PTEN, ß-catenin, ATM, and Chk2 were unaffected. p53 accumulation by proteasomal inhibition during G{alpha}12 deficiency suggested the role of G{alpha}12 in p53 stabilization. Constitutively active G{alpha}12 (G{alpha}12QL) or G{alpha}13 (G{alpha}13QL) promoted p53 accumulation with mdm4 induction in MCF10A cells. p53 accumulation by mdm4 overexpression, but no mdm4 induction by p53 overexpression, and small interfering RNA knockdown verified the regulatory role of mdm4 for p53 downstream of G{alpha}12/13. In control or G{alpha}12/G{alpha}13-deficient cells, genotoxic stress led to p53 accumulation. At concentrations increasing the flow cytometric pre-G1 phase, doxorubicin or etoposide treatment caused serine phosphorylations in G{alpha}12–/– or G{alpha}12/13–/– cells, but did not induce mdm4. G{alpha}12/13QL transfection failed to phosphorylate p53 at serines. Our results indicate that G{alpha}12/13 regulate basal p53 levels via mdm4, which constitutes a cell signaling pathway distinct from p53 phosphorylations elicited by genotoxic stress. (Mol Cancer Res 2007;5(5):473–84)




This article has been cited by other articles:


Home page
Mol. Cell. Biol.Home page
M. K. Cho, W. D. Kim, S. H. Ki, J.-I. Hwang, S. Choi, C. H. Lee, and S. G. Kim
Role of G{alpha}12 and G{alpha}13 as Novel Switches for the Activity of Nrf2, a Key Antioxidative Transcription Factor
Mol. Cell. Biol., September 1, 2007; 27(17): 6195 - 6208.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 2007 by the American Association for Cancer Research.